Date posted: November 12, 2019, 6:00 am
In this episode, we will discuss what is the latest and greatest from the GINA (Global INitiative for Asthma) 2019 guidelines, including new recommendations regarding rescue inhalers, tiotropium, and azithromycin for asthma.
Date posted: October 22, 2019, 6:00 am
In this episode, we discuss the newly published DAPA-HF trial, which studied dapagliflozin (a drug for diabetes) among patients who had heart failure with reduced ejection fraction (HFrEF) many of which did NOT have a history of diabetes.
Date posted: October 1, 2019, 6:00 am
In this episode, we provide an overview of chronic idiopathic constipation and discuss available treatment options with a particular focus on lubiprostone, linaclotide, plecanatide, and prucalopride.
Date posted: September 10, 2019, 6:00 am
In this episode, we will be discussing the recent updates in measles outbreaks, where the vaccination recommendations stand, and other preventative strategies.
Date posted: August 20, 2019, 6:00 am
We are proud to announce our 100th HelixTalk episode! In celebration, we sit down with Dr. Marc Abel, the Dean of the College of Pharmacy at RFUMS to discuss the profession of pharmacy and the future of pharmacy education.
Date posted: July 30, 2019, 6:00 am
In this episode, we enlist the help of Associate Dean for Student Affairs, Janeen Winnike, to discuss the various professional pharmacy organizations and the importance of networking via joining at least one as a student or pharmacist.
Date posted: July 9, 2019, 6:00 am
In this episode, we review guideline recommendations and recent evidence for secondary prevention of stroke, including risk factor modification, anticoagulant therapy (in patients with atrial fibrillation), and antiplatelet therapy (in patients with noncardioembolic stroke).
Date posted: June 18, 2019, 6:00 am
In this episode, we discuss the latest and the greatest updates regarding aspirin use in primary prevention and provide you with a summary of results from recently published primary literature.
Date posted: May 28, 2019, 6:00 am
In this episode we discuss the recent FDA approval of esketamine (Spravato) for the management of treatment resistant depression as an add on to oral antidepressant therapy. The agent is novel though so, too, may be its adverse effect profile and logistics of administration.
Date posted: May 7, 2019, 6:00 am
In this episode, we will review the pharmacology, efficacy, and safety of the most common NSAIDs on the market.